Related Articles
Antitumor necrosis factor‑α antibodies as a novel therapy for hepatocellular carcinoma
Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo
Expression of immune regulatory factors, chemokines and growth factors in differentiated gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells
Resveratrol ameliorates oxaliplatin‑induced neuropathic pain via anti‑inflammatory effects in rats